Innovation Drives The Future - Technological Trends Of Vacuum-assisted Breast Biopsy Needles And Manners' Opportunities

The vacuum-assisted breast biopsy (VABB) technique has evolved into the cornerstone of minimally invasive breast diagnosis since its inception. However, clinical demands are constantly increasing, and technological progress has never ceased. To address earlier, smaller, and more complex lesions, as well as the growing demands for diagnostic information volume, surgical experience, and cosmetic effects, the VABB biopsy needle is now at the starting point of a new round of technological innovation. This chapter will outline its future development trends and explore the role and opportunities that precision manufacturers like Manners are playing in this process.
I. Technological Development Trends Driven by Changes in Clinical Needs
1. More precise navigation and positioning
- Multimodal image fusion: In the future, VABB will be more deeply integrated with multimodal images (such as ultrasound, MRI, cone-beam CT). This requires that the biopsy needle not only be compatible with X-ray stereotactic positioning, but also its material and design need to be optimized to adapt to ultrasound (enhanced echoicity) and MRI (using compatible materials such as titanium alloy or ceramics, avoiding artifacts) guidance. The biopsy needle itself may integrate a micro-positioning sensor, which can be real-time aligned with the imaging system to achieve surgical navigation-level precise positioning.
- Artificial intelligence assistance: AI algorithms can automatically analyze images, outline the lesion area, plan the optimal puncture path and sampling points, and even can real-time identify whether the sample contains the target calcification (through intrapuncture micro-optical coherence tomography and other technologies), achieving "intelligent sampling".
2. Less invasive and better cosmetic effect
- Efficient sampling under finer needle diameters: There is a clinical need to use finer needle diameters (such as 16G or even 18G) to reduce trauma and minimize scarring, but it needs to overcome the challenge of potentially reduced sample volume. Future needle devices may innovate in cutting mechanisms (such as high-frequency oscillation cutting), groove designs (such as multi-window, spiral), and negative pressure systems, achieving the same sampling efficiency and tissue integrity as larger needle diameters under fine needle diameters.
- Through natural cavities or concealed incisions: Exploring access through more concealed paths such as axilla or areola for biopsy, further meeting cosmetic needs. This poses new requirements for the flexibility and controllability of the biopsy needle, and may require the application of superelastic materials such as nickel-titanium alloys to manufacture some components.
3. More comprehensive intraoperative diagnostic and therapeutic functions
- "Biopsy-Ablation" integration: After obtaining diagnostic samples, the same needle can switch to an ablation electrode (radiofrequency, microwave or cryotherapy), performing immediate ablation treatment for confirmed benign small tumors (such as fibroadenoma) or low-risk malignant lesions, achieving "one-time completion" of diagnostic biopsy and radical treatment.
- Rapid on-site molecular diagnosis: The inner cavity or handle of the future biopsy needle may integrate a microfluidic chip, which can perform rapid initial screening of molecular markers in tissue fluid within minutes after sampling, providing real-time information for surgical decision-making.
4. More intelligent systems and consumables
- Force feedback and safety control: The needle tip integrates a micro-force sensor, which can monitor the resistance during puncture and cutting in real time. In case of abnormal resistance (such as touching ribs or dense calcification), it can automatically pause or adjust, enhancing safety.
- Digital management and traceability: Each biopsy needle has a unique RFID or QR code, recording production information and sterilization batches. During use, it can automatically be bound to patient information, surgical parameters, etc., achieving full digital management of consumable usage throughout the process.
II. New Challenges to Core Manufacturing Technologies
This trend poses new technological challenges and opportunities for manufacturers like Manners:
1. Cross-border applications of materials science:
- MRI-compatible materials: It is necessary to master the precise processing techniques of titanium alloys, special ceramics or polymer composite materials. The cutting performance, polishing processes of these materials are completely different from those of stainless steel.
- Functional material integration: Exploring the manufacturing and connection techniques for integrating piezoelectric ceramics (for ultrasonic transduction) and shape memory alloys (for controllable bending) in specific parts of the needle body.
2. Precision processing at extreme scales:
- Microstructure processing: To achieve efficient sampling grooves and smooth inner cavities within a finer needle diameter (such as 16G, with an outer diameter of approximately 1.65mm), ultra-precise micro-milling, micro-drilling and micro-sanding technologies are required. Extreme requirements have been set for the tools, fixtures and programming of Citizen-class machine tools.
- Complex curved surface and inner cavity polishing: For designs integrating internal channels or multi-functional cavities, how to uniformly perform electrolytic polishing or other ultra-precision polishing on the extremely complex inner curved surfaces with a large depth-to-diameter ratio is the key to ensuring performance.
3. Multi-process integration and assembly:
- Hybrid material connection: How to securely, biocompatible and functionally unaffected connect metal needle tubes with polymer sensor housings, or different metal components (such as laser welding, micro riveting).
- Extreme challenges in cleaning and sterilization: After integrating internal microelectronics or microchannels, traditional ultrasonic cleaning and ethylene oxide sterilization may no longer be applicable. New cleaning verification methods and low-temperature sterilization processes (such as hydrogen peroxide plasma) need to be developed.
III. Opportunities and Strategic Pathways of Manners
In light of future trends, Manners' opportunity lies in upgrading its core capability of "ultra-precision manufacturing" from its current status as a "metal cutting expert" to that of a "provider of complex component solutions for minimally invasive interventional devices".
1. From "Manufacturing" to "Collaborative R&D": Actively collaborate with leading international brands of biopsy systems and participate in the early research and development of their next-generation products. With a profound understanding of the limits of metal processing techniques, provide manufacturability analysis for the conceptual design of clinical innovation, and jointly transform creativity into mass-producible high-performance products.
2. Expand the material and process capability matrix: While deeply focusing on 316 stainless steel, strategically lay out precision processing technologies for titanium alloys, nickel-titanium alloys, and medical polymers. Invest in special equipment for micro-processing and heterogeneous material assembly to build a broader technological moat.
3. Embrace digital and intelligent manufacturing: Fully digitize manufacturing process data (equipment parameters, test results), utilize big data analysis to optimize process windows, achieve predictive quality control and adaptive process adjustments. This not only further enhances product consistency but also provides customers with detailed digital production archives, enhancing trust.
4. Deepen the quality system and adapt to higher regulations: As products integrate more functions (such as sensing, drug delivery), their regulatory classification and risk levels may change. Need to plan ahead for higher-level quality management system requirements applicable to active or complex devices, preparing for the acceptance of more complex product orders.
Conclusion

The future of vacuum-assisted breast biopsy needles is evolving towards greater precision, minimally invasive procedures, intelligence, and integration. This evolution is not only a progress in clinical medicine, but also a test of the ultimate capabilities of high-end precision manufacturing. For Manners, future market competitiveness will no longer solely depend on whether a stainless steel tube can be processed to an accuracy of ±0.01mm, but rather on whether multiple new materials, new structures, and new functions can be integrated within a small space with the same or even higher precision and reliability. This is both a challenge and a historic opportunity to shift from the "manufacturing环节" of the industrial chain to the "core value creation环节". Through continuous technological foresight, firm R&D investment, and close alignment with clinical needs, Manners is expected to thrive in the global innovation wave of minimally invasive diagnostic and therapeutic devices, evolving from an outstanding "manufacturer" to one of the leaders in the future.